title: Osteonecrosis in children treated for lymphoma or solid tumors.
abstract: OBJECTIVE
  The purpose of this study was to find out the incidence of and clinical risk factors for magnetic resonance imaging (MRI)-detected osteonecrosis (ON) in children treated for lymphoma or solid tumors.
  
  
  METHODS
  The development of ON was studied in 32 childhood cancer patients who underwent MRI scanning of the lower extremities at the end of their treatment. The underlying malignancy was Wilms tumor in 8 patients, non-Hodgkin lymphoma (NHL) in 8, Hodgkin disease (HD) in 7, rhabdomyosarcoma in 6, and other occasional solid tumors in 3 patients.
  
  
  RESULTS
  Six of the 32 patients (19%) had ON. The mean age of the patients with ON at diagnosis was 12.7 years compared with 5.8 years for the patients without ON (P<0.001). All the patients with ON had either HD (4 patients) or NHL (2 patients). Two (33%) of the patients with ON were symptomatic.
  
  
  CONCLUSIONS
  ON in MRI was found to be a common complication in children after treatment for HD or NHL. The risk for ON seems to be very low in patients with other solid tumors even when they receive high cumulative doses of dexamethasone.
authors.affiliation: Department of Pediatrics, Oulu University Hospital, Oulu, Finland. rsalonen@paju.oulu.fi
authors.forename: Riitta A
authors.initials: RA
authors.lastname: Niinimäki
authors.forename: Arja H
authors.initials: AH
authors.lastname: Harila-Saari
authors.forename: Airi E
authors.initials: AE
authors.lastname: Jartti
authors.forename: Raija M
authors.initials: RM
authors.lastname: Seuri
authors.forename: Pekka V
authors.initials: PV
authors.lastname: Riikonen
authors.forename: Eija L
authors.initials: EL
authors.lastname: Pääkkö
authors.forename: Merja I
authors.initials: MI
authors.lastname: Möttönen
authors.forename: Marjatta
authors.initials: M
authors.lastname: Lanning
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015994:Incidence; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis; D012307:Risk Factors
chemical_list: D003907:Dexamethasone